BioSpace News Archive

Akoya Biosciences, Inc. today announced that it will release financial results for the second quarter of 2023 after the market close on Monday, August 7th , 2023.

Apnimed, Inc. announced today that it will be participating in a fireside chat at the William Blair Conference, Transitioning Biotech Breakthroughs to Commercial Success, taking place virtually on Tuesday, July 18, 2023 at 8 a.m. ET.

Ultragenyx Pharmaceutical Inc. today announced that it has appointed Howard Horn as executive vice president and chief financial officer (CFO) effective October 16, 2023.

LianBio today announced a clinical supply agreement with AstraZeneca in China to evaluate the safety and efficacy of BBP-398, an investigational SHP2 inhibitor.

Lumos Pharma, Inc. will participate in the Oppenheimer 2023 Life Sciences Summit to be held July 18th – 20th in Montauk, NY, during which discussions with investors will take place.

Konica Minolta Healthcare Americas, Inc., announced the introduction of PocketPro H2, a new wireless handheld ultrasound device for general imaging in point-of-care applications.

Ocular Therapeutix, Inc. today announced the appointment of Adrienne L. Graves, Ph.D., to its Board of Directors.

Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced that the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation under the Generating Antibiotic Incentives Now (GAIN) Act for AR-301, a fully human IgG1 monoclonal antibody (mAb) currently in Phase 3 clinical development as an adjunctive therapy for pneumonia caused by gram-positive Staphylococcus aureus in critically ill hospitalized patients.

Bridge to Life Ltd., a leading global supplier of organ preservation and perfusion technologies, announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress.

Caristo Diagnostics Limited, a global leader in cardiac and vascular disease diagnostics and risk prediction, announces that it is deploying its latest CaRi-Heart® technology in National Health Service hospitals as part of a new coronary artery disease management pathway pilot.